Research Focus
This systematic review investigates the effects of glucagon-like peptide-1 (GLP-1) agonists on polycystic ovary syndrome (PCOS), examining their influence on insulin resistance, hormonal regulation, weight management, and ovulatory function. The review aims to explore the mechanisms by which GLP-1 agonists may improve metabolic and reproductive outcomes in PCOS, providing insights into their potential as a targeted therapeutic option for symptom management and long-term health improvement.
Responsibilities
In this role, I conducted a systematic review evaluating the effects of GLP-1 agonist drugs on menstrual cycle regularity and related symptoms. Through this process, I gained hands-on experience with the literature review workflow, including developing effective search strategies, screening research articles, and preparing studies for future data analysis. This work enhanced my ability to critically assess scientific literature and strengthened my skills in organizing and synthesizing complex research findings.